Dung-Fang Lee

Citée par

	Toutes	Depuis 2020
Citations	12942	3989
indice h	47	33
indice i10	79	66

940

470

235

705

20052006200720082009201020112012201320142015201620172018201920202021202220232024202582 159 179 251 324 408 572 796 889 929 868 853 821 888 829 853 902 795 720 648 70

Accès public

Tout afficher

70 articles

2 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Mien-Chie HungChina Medical University, TaiwanAdresse e-mail validée de cmu.edu.tw
Julian A. GingoldMontefiore Medical Center, Albert Einstein College of MedicineAdresse e-mail validée de post.harvard.edu
Jie SuResearch Fellow, Cancer Biology & Genetics, Sloan Kettering InstituteAdresse e-mail validée de mskcc.org
Christoph SchanielAssistant Professor, Icahn School of Medicine at Mount SinaiAdresse e-mail validée de mssm.edu
Chun-Te ChenOBI pharmaAdresse e-mail validée de obipharma.com
Jer-Yen YangAssociate Professor of Cancer and Developmental Biology, China Medical University, TaiwanAdresse e-mail validée de cmu.edu.tw
Jung-Mao HsuChina Medical University, TaiwanAdresse e-mail validée de mail.cmu.edu.tw
Chao-Kai ChouUT MD Anderson Cancer CenterAdresse e-mail validée de mdanderson.org
Yen-Sin AngGladstone Institutes & University of California San FranciscoAdresse e-mail validée de gladstone.ucsf.edu
Mo LiuNeural Stem Cell Institution, MD Anderson Cancer Center, Wuhan UniversityAdresse e-mail validée de neuralsci.org
Betty ChangGraduate Student, Icahn School of Medicine at Mount SinaiAdresse e-mail validée de mssm.edu
Fuu-Jen TsaiChina Medical University,TaiwanAdresse e-mail validée de mail.cmuh.org.tw
An XuUniversity of Texas Health Science Center at HoustonAdresse e-mail validée de uth.tmc.edu
Ana SevillaPhDAdresse e-mail validée de ub.edu
Avinash Waghray, PhDCenter for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical SchoolAdresse e-mail validée de mgh.harvard.edu
dandan zhuThe University of Texas Health Science CenterAdresse e-mail validée de uth.tmc.edu
Jianlong WangColumbia University Irving Medical CenterAdresse e-mail validée de cumc.columbia.edu
Francesca AguiloWallenberg Center for Molecular Medicine and Department of Molecular Biology, Umeå UniversityAdresse e-mail validée de umu.se
Ruoji ZhouUCLAAdresse e-mail validée de mednet.ucla.edu
Michael RendlIcahn School of Medicine at Mount SinaiAdresse e-mail validée de mssm.edu

Suivre

Dung-Fang Lee

UTHealth McGovern Medical School

Adresse e-mail validée de uth.tmc.edu - Page d'accueil

Cancer Stem Cells and Disease Modeling


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a MCT Hu, DF Lee, W Xia, LS Golfman, F Ou-Yang, JY Yang, Y Zou, S Bao, ... Cell 117 (2), 225-237, 2004	1107	2004
IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway DF Lee, HP Kuo, CT Chen, JM Hsu, CK Chou, Y Wei, HL Sun, LY Li, ... Cell 130 (3), 440-455, 2007	833	2007
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome X Carvajal-Vergara, A Sevilla, SL D’Souza, YS Ang, C Schaniel, DF Lee, ... Nature 465 (7299), 808-812, 2010	824	2010
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation JY Yang, CS Zong, W Xia, H Yamaguchi, Q Ding, X Xie, JY Lang, CC Lai, ... Nature cell biology 10 (2), 138-148, 2008	823	2008
Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin Q Ding, W Xia, JC Liu, JY Yang, DF Lee, J Xia, G Bartholomeusz, Y Li, ... Molecular cell 19 (2), 159-170, 2005	700	2005
Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network YS Ang, SY Tsai, DF Lee, J Monk, J Su, K Ratnakumar, J Ding, Y Ge, ... Cell 145 (2), 183-197, 2011	671	2011
KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma J Ling, Y Kang, R Zhao, Q Xia, DF Lee, Z Chang, J Li, B Peng, JB Fleming, ... Cancer cell 21 (1), 105-120, 2012	574	2012
Degradation of Mcl-1 by β-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization Q Ding, X He, JM Hsu, W Xia, CT Chen, LY Li, DF Lee, JC Liu, Q Zhong, ... Molecular and cellular biology 27 (11), 4006-4017, 2007	481	2007
KEAP1 E3 ligase-mediated downregulation of NF-κB signaling by targeting IKKβ DF Lee, HP Kuo, M Liu, CK Chou, W Xia, Y Du, J Shen, CT Chen, L Huo, ... Molecular cell 36 (1), 131-140, 2009	447	2009
The crosstalk of mTOR/S6K1 and Hedgehog pathways Y Wang, Q Ding, CJ Yen, W Xia, JG Izzo, JY Lang, CW Li, JL Hsu, ... Cancer cell 21 (3), 374-387, 2012	410	2012
Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2 SC Wang, HC Lien, W Xia, IF Chen, HW Lo, Z Wang, M Ali-Seyed, DF Lee, ... Cancer cell 6 (3), 251-261, 2004	376	2004
Coordination of m6A mRNA methylation and gene transcription by ZFP217 regulates pluripotency and reprogramming F Aguilo, F Zhang, A Sancho, M Fidalgo, S Di Cecilia, A Vashisht, DF Lee, ... Cell stem cell 17 (6), 689-704, 2015	328	2015
FOXO1 is an essential regulator of pluripotency in human embryonic stem cells X Zhang, S Yalcin, DF Lee, TYJ Yeh, SM Lee, J Su, SK Mungamuri, ... Nature cell biology 13 (9), 1092-1099, 2011	314	2011
Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor DK Giri, M Ali-Seyed, LY Li, DF Lee, P Ling, G Bartholomeusz, SC Wang, ... Molecular and cellular biology 25 (24), 11005-11018, 2005	272	2005
Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3β activity and associates with poor prognosis in human breast cancer Q Ding, X He, W Xia, JM Hsu, CT Chen, LY Li, DF Lee, JY Yang, X Xie, ... Cancer research 67 (10), 4564-4571, 2007	249	2007
Modeling familial cancer with induced pluripotent stem cells DF Lee, J Su, HS Kim, B Chang, D Papatsenko, R Zhao, Y Yuan, ... Cell 161 (2), 240-254, 2015	228	2015
Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer Q Ding, L Huo, JY Yang, W Xia, Y Wei, Y Liao, CJ Chang, Y Yang, CC Lai, ... Cancer research 68 (15), 6109-6117, 2008	228	2008
Phosphorylation/Cytoplasmic Localization of p21^Cip1/WAF1 Is Associated with HER2/*neu* Overexpression and Provides a Novel Combination Predictor for Poor … W Xia, JS Chen, X Zhou, PR Sun, DF Lee, Y Liao, BP Zhou, MC Hung Clinical cancer research 10 (11), 3815-3824, 2004	207	2004
Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1 C Li, J Ao, J Fu, DF Lee, J Xu, D Lonard, BW O'Malley Oncogene 30 (42), 4350-4364, 2011	199	2011
Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells SY Tsai, C Clavel, S Kim, YS Ang, L Grisanti, DF Lee, K Kelley, M Rendl Stem cells 28 (2), 221-228, 2010	179	2010

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs